Study of the Clinical and Radiological Impact of Ravulizumab in People With Neuromyelitis Optica Spectrum Disorder

NCT06398158 · clinicaltrials.gov ↗

RECRUITING

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Neuromyelitis Optica

Interventions

DRUG: Ravulizumab

Sponsor

University of Texas Southwestern Medical Center

Collaborators

[object Object]